Application of advanced brain positron emission tomography–based molecular imaging for a biological framework in neurodegenerative proteinopathies

Abstract Introduction A rapid transition from a clinical‐based classification to a pathology‐based classification of neurodegenerative conditions, largely promoted by the increasing availability of imaging biomarkers, is emerging. The Framework for Innovative Multi‐tracer molecular Brain Imaging, fu...

Full description

Bibliographic Details
Main Authors: Daniela Perani, Leonardo Iaccarino, Andreas H. Jacobs, IMBI Brain Imaging Working Group, Adriaan A. Lammertsma, Agneta Nordberg, Albert D. Windhorst, Alexander Gerhard, Alexandra Winkeler, Anthony Gee, Bertrand Kuhnast, Christer Halldin, David Brooks, Elena Rodriguez‐Vieitez, Federico E. Turkheimer, Francisco López‐Picón, Gitte M. Knudsen, Johnny Vercouillie, Juha O. Rinne, Karl Herholz, Koen Van Laere, Andrea Varrone, Marie Joao Santiago‐Ribeiro, Matthias M. Herth, Michael A. Carroll, Sylvie Chalon, Michel Bottlaender, Oskar Hansson, Paul Edison, Rainer Hinz, Ronald Boellaard, Rosa Maria Moresco, Sabina Pappata
Format: Article
Language:English
Published: Wiley 2019-12-01
Series:Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring
Subjects:
Tau
Online Access:https://doi.org/10.1016/j.dadm.2019.02.004
id doaj-50bd95b6267e48ed9f70a0858de39d47
record_format Article
spelling doaj-50bd95b6267e48ed9f70a0858de39d472020-11-25T03:43:18ZengWileyAlzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring2352-87292019-12-0111132733210.1016/j.dadm.2019.02.004Application of advanced brain positron emission tomography–based molecular imaging for a biological framework in neurodegenerative proteinopathiesDaniela Perani0Leonardo Iaccarino1Andreas H. Jacobs2IMBI Brain Imaging Working GroupAdriaan A. Lammertsma3Agneta Nordberg4Albert D. Windhorst5Alexander Gerhard6Alexandra Winkeler7Andreas H. Jacobs8Anthony Gee9Bertrand Kuhnast10Christer Halldin11Daniela Perani12David Brooks13Elena Rodriguez‐Vieitez14Federico E. Turkheimer15Francisco López‐Picón16Gitte M. Knudsen17Johnny Vercouillie18Juha O. Rinne19Karl Herholz20Koen Van Laere21Andrea Varrone22Marie Joao Santiago‐Ribeiro23Matthias M. Herth24Michael A. Carroll25Sylvie Chalon26Michel Bottlaender27Oskar Hansson28Paul Edison29Rainer Hinz30Ronald Boellaard31Rosa Maria Moresco32Sabina Pappata33Vita‐Salute San Raffaele UniversityMilanItalyVita‐Salute San Raffaele UniversityMilanItalyEuropean Institute for Molecular Imaging, University of MünsterMünsterGermanyVita‐Salute San Raffaele UniversityMilanItalyVita‐Salute San Raffaele UniversityMilanItalyVita‐Salute San Raffaele UniversityMilanItalyVita‐Salute San Raffaele UniversityMilanItalyVita‐Salute San Raffaele UniversityMilanItalyVita‐Salute San Raffaele UniversityMilanItalyVita‐Salute San Raffaele UniversityMilanItalyVita‐Salute San Raffaele UniversityMilanItalyVita‐Salute San Raffaele UniversityMilanItalyVita‐Salute San Raffaele UniversityMilanItalyVita‐Salute San Raffaele UniversityMilanItalyVita‐Salute San Raffaele UniversityMilanItalyVita‐Salute San Raffaele UniversityMilanItalyVita‐Salute San Raffaele UniversityMilanItalyVita‐Salute San Raffaele UniversityMilanItalyVita‐Salute San Raffaele UniversityMilanItalyVita‐Salute San Raffaele UniversityMilanItalyVita‐Salute San Raffaele UniversityMilanItalyVita‐Salute San Raffaele UniversityMilanItalyVita‐Salute San Raffaele UniversityMilanItalyVita‐Salute San Raffaele UniversityMilanItalyVita‐Salute San Raffaele UniversityMilanItalyVita‐Salute San Raffaele UniversityMilanItalyVita‐Salute San Raffaele UniversityMilanItalyVita‐Salute San Raffaele UniversityMilanItalyVita‐Salute San Raffaele UniversityMilanItalyVita‐Salute San Raffaele UniversityMilanItalyVita‐Salute San Raffaele UniversityMilanItalyVita‐Salute San Raffaele UniversityMilanItalyVita‐Salute San Raffaele UniversityMilanItalyVita‐Salute San Raffaele UniversityMilanItalyAbstract Introduction A rapid transition from a clinical‐based classification to a pathology‐based classification of neurodegenerative conditions, largely promoted by the increasing availability of imaging biomarkers, is emerging. The Framework for Innovative Multi‐tracer molecular Brain Imaging, funded by the EU Joint Program ‐ Neurodegenerative Disease Research 2016 “Working Groups for Harmonisation and Alignment in Brain Imaging Methods for Neurodegeneration,” aimed at providing a roadmap for the applications of established and new molecular imaging techniques in dementia. Methods We consider current and future implications of adopting a pathology‐based framework for the use and development of positron emission tomography techniques. Results This approach will enhance efforts to understand the multifactorial etiology of Alzheimer's disease and other dementias. Discussion The availability of pathology biomarkers will soon transform clinical and research practice. Crucially, a comprehensive understanding of strengths and caveats of these techniques will promote an informed use to take full advantage of these tools.https://doi.org/10.1016/j.dadm.2019.02.004PET molecular imagingRadiotracersProtheinopathiesAmyloidTauNeuroinflammation
collection DOAJ
language English
format Article
sources DOAJ
author Daniela Perani
Leonardo Iaccarino
Andreas H. Jacobs
IMBI Brain Imaging Working Group
Adriaan A. Lammertsma
Agneta Nordberg
Albert D. Windhorst
Alexander Gerhard
Alexandra Winkeler
Andreas H. Jacobs
Anthony Gee
Bertrand Kuhnast
Christer Halldin
Daniela Perani
David Brooks
Elena Rodriguez‐Vieitez
Federico E. Turkheimer
Francisco López‐Picón
Gitte M. Knudsen
Johnny Vercouillie
Juha O. Rinne
Karl Herholz
Koen Van Laere
Andrea Varrone
Marie Joao Santiago‐Ribeiro
Matthias M. Herth
Michael A. Carroll
Sylvie Chalon
Michel Bottlaender
Oskar Hansson
Paul Edison
Rainer Hinz
Ronald Boellaard
Rosa Maria Moresco
Sabina Pappata
spellingShingle Daniela Perani
Leonardo Iaccarino
Andreas H. Jacobs
IMBI Brain Imaging Working Group
Adriaan A. Lammertsma
Agneta Nordberg
Albert D. Windhorst
Alexander Gerhard
Alexandra Winkeler
Andreas H. Jacobs
Anthony Gee
Bertrand Kuhnast
Christer Halldin
Daniela Perani
David Brooks
Elena Rodriguez‐Vieitez
Federico E. Turkheimer
Francisco López‐Picón
Gitte M. Knudsen
Johnny Vercouillie
Juha O. Rinne
Karl Herholz
Koen Van Laere
Andrea Varrone
Marie Joao Santiago‐Ribeiro
Matthias M. Herth
Michael A. Carroll
Sylvie Chalon
Michel Bottlaender
Oskar Hansson
Paul Edison
Rainer Hinz
Ronald Boellaard
Rosa Maria Moresco
Sabina Pappata
Application of advanced brain positron emission tomography–based molecular imaging for a biological framework in neurodegenerative proteinopathies
Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring
PET molecular imaging
Radiotracers
Protheinopathies
Amyloid
Tau
Neuroinflammation
author_facet Daniela Perani
Leonardo Iaccarino
Andreas H. Jacobs
IMBI Brain Imaging Working Group
Adriaan A. Lammertsma
Agneta Nordberg
Albert D. Windhorst
Alexander Gerhard
Alexandra Winkeler
Andreas H. Jacobs
Anthony Gee
Bertrand Kuhnast
Christer Halldin
Daniela Perani
David Brooks
Elena Rodriguez‐Vieitez
Federico E. Turkheimer
Francisco López‐Picón
Gitte M. Knudsen
Johnny Vercouillie
Juha O. Rinne
Karl Herholz
Koen Van Laere
Andrea Varrone
Marie Joao Santiago‐Ribeiro
Matthias M. Herth
Michael A. Carroll
Sylvie Chalon
Michel Bottlaender
Oskar Hansson
Paul Edison
Rainer Hinz
Ronald Boellaard
Rosa Maria Moresco
Sabina Pappata
author_sort Daniela Perani
title Application of advanced brain positron emission tomography–based molecular imaging for a biological framework in neurodegenerative proteinopathies
title_short Application of advanced brain positron emission tomography–based molecular imaging for a biological framework in neurodegenerative proteinopathies
title_full Application of advanced brain positron emission tomography–based molecular imaging for a biological framework in neurodegenerative proteinopathies
title_fullStr Application of advanced brain positron emission tomography–based molecular imaging for a biological framework in neurodegenerative proteinopathies
title_full_unstemmed Application of advanced brain positron emission tomography–based molecular imaging for a biological framework in neurodegenerative proteinopathies
title_sort application of advanced brain positron emission tomography–based molecular imaging for a biological framework in neurodegenerative proteinopathies
publisher Wiley
series Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring
issn 2352-8729
publishDate 2019-12-01
description Abstract Introduction A rapid transition from a clinical‐based classification to a pathology‐based classification of neurodegenerative conditions, largely promoted by the increasing availability of imaging biomarkers, is emerging. The Framework for Innovative Multi‐tracer molecular Brain Imaging, funded by the EU Joint Program ‐ Neurodegenerative Disease Research 2016 “Working Groups for Harmonisation and Alignment in Brain Imaging Methods for Neurodegeneration,” aimed at providing a roadmap for the applications of established and new molecular imaging techniques in dementia. Methods We consider current and future implications of adopting a pathology‐based framework for the use and development of positron emission tomography techniques. Results This approach will enhance efforts to understand the multifactorial etiology of Alzheimer's disease and other dementias. Discussion The availability of pathology biomarkers will soon transform clinical and research practice. Crucially, a comprehensive understanding of strengths and caveats of these techniques will promote an informed use to take full advantage of these tools.
topic PET molecular imaging
Radiotracers
Protheinopathies
Amyloid
Tau
Neuroinflammation
url https://doi.org/10.1016/j.dadm.2019.02.004
work_keys_str_mv AT danielaperani applicationofadvancedbrainpositronemissiontomographybasedmolecularimagingforabiologicalframeworkinneurodegenerativeproteinopathies
AT leonardoiaccarino applicationofadvancedbrainpositronemissiontomographybasedmolecularimagingforabiologicalframeworkinneurodegenerativeproteinopathies
AT andreashjacobs applicationofadvancedbrainpositronemissiontomographybasedmolecularimagingforabiologicalframeworkinneurodegenerativeproteinopathies
AT imbibrainimagingworkinggroup applicationofadvancedbrainpositronemissiontomographybasedmolecularimagingforabiologicalframeworkinneurodegenerativeproteinopathies
AT adriaanalammertsma applicationofadvancedbrainpositronemissiontomographybasedmolecularimagingforabiologicalframeworkinneurodegenerativeproteinopathies
AT agnetanordberg applicationofadvancedbrainpositronemissiontomographybasedmolecularimagingforabiologicalframeworkinneurodegenerativeproteinopathies
AT albertdwindhorst applicationofadvancedbrainpositronemissiontomographybasedmolecularimagingforabiologicalframeworkinneurodegenerativeproteinopathies
AT alexandergerhard applicationofadvancedbrainpositronemissiontomographybasedmolecularimagingforabiologicalframeworkinneurodegenerativeproteinopathies
AT alexandrawinkeler applicationofadvancedbrainpositronemissiontomographybasedmolecularimagingforabiologicalframeworkinneurodegenerativeproteinopathies
AT andreashjacobs applicationofadvancedbrainpositronemissiontomographybasedmolecularimagingforabiologicalframeworkinneurodegenerativeproteinopathies
AT anthonygee applicationofadvancedbrainpositronemissiontomographybasedmolecularimagingforabiologicalframeworkinneurodegenerativeproteinopathies
AT bertrandkuhnast applicationofadvancedbrainpositronemissiontomographybasedmolecularimagingforabiologicalframeworkinneurodegenerativeproteinopathies
AT christerhalldin applicationofadvancedbrainpositronemissiontomographybasedmolecularimagingforabiologicalframeworkinneurodegenerativeproteinopathies
AT danielaperani applicationofadvancedbrainpositronemissiontomographybasedmolecularimagingforabiologicalframeworkinneurodegenerativeproteinopathies
AT davidbrooks applicationofadvancedbrainpositronemissiontomographybasedmolecularimagingforabiologicalframeworkinneurodegenerativeproteinopathies
AT elenarodriguezvieitez applicationofadvancedbrainpositronemissiontomographybasedmolecularimagingforabiologicalframeworkinneurodegenerativeproteinopathies
AT federicoeturkheimer applicationofadvancedbrainpositronemissiontomographybasedmolecularimagingforabiologicalframeworkinneurodegenerativeproteinopathies
AT franciscolopezpicon applicationofadvancedbrainpositronemissiontomographybasedmolecularimagingforabiologicalframeworkinneurodegenerativeproteinopathies
AT gittemknudsen applicationofadvancedbrainpositronemissiontomographybasedmolecularimagingforabiologicalframeworkinneurodegenerativeproteinopathies
AT johnnyvercouillie applicationofadvancedbrainpositronemissiontomographybasedmolecularimagingforabiologicalframeworkinneurodegenerativeproteinopathies
AT juhaorinne applicationofadvancedbrainpositronemissiontomographybasedmolecularimagingforabiologicalframeworkinneurodegenerativeproteinopathies
AT karlherholz applicationofadvancedbrainpositronemissiontomographybasedmolecularimagingforabiologicalframeworkinneurodegenerativeproteinopathies
AT koenvanlaere applicationofadvancedbrainpositronemissiontomographybasedmolecularimagingforabiologicalframeworkinneurodegenerativeproteinopathies
AT andreavarrone applicationofadvancedbrainpositronemissiontomographybasedmolecularimagingforabiologicalframeworkinneurodegenerativeproteinopathies
AT mariejoaosantiagoribeiro applicationofadvancedbrainpositronemissiontomographybasedmolecularimagingforabiologicalframeworkinneurodegenerativeproteinopathies
AT matthiasmherth applicationofadvancedbrainpositronemissiontomographybasedmolecularimagingforabiologicalframeworkinneurodegenerativeproteinopathies
AT michaelacarroll applicationofadvancedbrainpositronemissiontomographybasedmolecularimagingforabiologicalframeworkinneurodegenerativeproteinopathies
AT sylviechalon applicationofadvancedbrainpositronemissiontomographybasedmolecularimagingforabiologicalframeworkinneurodegenerativeproteinopathies
AT michelbottlaender applicationofadvancedbrainpositronemissiontomographybasedmolecularimagingforabiologicalframeworkinneurodegenerativeproteinopathies
AT oskarhansson applicationofadvancedbrainpositronemissiontomographybasedmolecularimagingforabiologicalframeworkinneurodegenerativeproteinopathies
AT pauledison applicationofadvancedbrainpositronemissiontomographybasedmolecularimagingforabiologicalframeworkinneurodegenerativeproteinopathies
AT rainerhinz applicationofadvancedbrainpositronemissiontomographybasedmolecularimagingforabiologicalframeworkinneurodegenerativeproteinopathies
AT ronaldboellaard applicationofadvancedbrainpositronemissiontomographybasedmolecularimagingforabiologicalframeworkinneurodegenerativeproteinopathies
AT rosamariamoresco applicationofadvancedbrainpositronemissiontomographybasedmolecularimagingforabiologicalframeworkinneurodegenerativeproteinopathies
AT sabinapappata applicationofadvancedbrainpositronemissiontomographybasedmolecularimagingforabiologicalframeworkinneurodegenerativeproteinopathies
_version_ 1724520768377716736